Gina Shishima is the U.S. Chief Strategy and Operations Partner for Norton Rose Fulbright, where she also serves on the US and Global management committees. She was previously the U.S. Head of Intellectual Property and the U.S. Chief Diversity Officer. She enjoys working with her clients to strategize and provide practical solutions related to all aspects of patent law—including patent prosecution and portfolio management, post-grant challenges, patent litigation and IP due diligence—in the areas of biotechnology, pharmaceuticals, and medical technology. Her clients include public and private life sciences companies, as well as hospitals and universities.
Among other awards, she has been named one of the 500 Leading Lawyers in America by Lawdragon, in Chamber’s USA for intellectual property, in Legal 500 in Life Sciences, and in Best Lawyer’s as Austin “Lawyer of the Year” for both biotechnology law and patent law. Gina previously co-chaired the Women’s Leadership Network of the National Asian Pacific American Bar Association (NAPABA), where she also served on its Board of Directors as a Regional Governor. In addition to being on the Board of Advancing Justice AAJC (D.C.), she is on the Executive Committee for the Center for Women in Law. Gina has been recognized for her efforts in the AAPI legal community as a recipient of the NAPABA Trailblazer Award in 2021 and the Judge Wellington Chew Award in 2017 from the Asian Pacific Interest Section of the Texas State Bar.
After earning an A.B. in Biochemistry from Columbia University and a Ph.D. in Molecular Biology from Princeton University, Gina received her law degree from the University of California, Berkeley, where she was on the California Law Review. She is admitted to practice in New York and Texas and is registered attorney with the United States Patent and Trademark Office.